2024

Tatarova Z. Using the tumour microenvironment to improve therapy efficacy. Nat Rev Cancer. 2024 Apr 26. doi: 10.1038/s41568-024-00693-8. Epub ahead of print. PMID: 38671199.

Bhagavatula SK, Panikkanvalappil SR, Tokuda J, Levesque V, Tatarova Z, Liu G, Markert JE, Jonas O. Superparamagnetic iron oxide nanoparticle enhanced percutaneous microwave ablation: Ex-vivo characterization using magnetic resonance thermometry. Med Phys. 2024 Mar 21. doi: 10.1002/mp.17040. Epub ahead of print. PMID: 38513254.

 

2023

Doha ZO, Wang X, Calistri NL, Eng J, Daniel CJ, Ternes L, Kim EN, Pelz C, Munks M, Betts C, Kwon S, Bucher E, Li X, Waugh T, Tatarova Z, Blumberg D, Ko A, Kirchberger N, Pietenpol JA, Sanders ME, Langer EM, Dai MS, Mills G, Chin K, Chang YH, Coussens LM, Gray JW, Heiser LM, Sears RC. MYC Deregulation and PTEN Loss Model Tumor and Stromal Heterogeneity of Aggressive Triple-Negative Breast Cancer. Nat Commun. 2023 Sep 13;14(1):5665. doi: 10.1038/s41467-023-40841-6. PMID: 37704631

Tatarova Z, Blumberg DC, Bensen A, Mills GB, Jonas O. Cells. Panobinostat Induced Spatial In Situ Biomarkers Predictive of Anti-PD-1 Efficacy in Mouse Mammary Carcinoma. 2023 Jan 13;12(2):308. doi: 10.3390/cells12020308. PMID: 36672243 Free PMC article.